Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
870 Targeting GCN2 kinase-driven stress response inactivation to restore tumor immunity in metastatic triple negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.